Announcement on Correction of 2025 Semi-annual Report
Filed with SSE · · 11 pages · Chinese
Bide Pharmatech Co. Ltd. on 6ix
Earlier from Bide Pharmatech
- Announcement on Completing Industrial and Commercial Change and Obtaining Business Licenses
- Announcement on Making Provisions for Asset Impairment for the Half-Year Period of 2025
- Announcement on Resignation of Director and Election of Employee Director
- Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025
- Notice on Convening the 4th Extraordinary General Meeting in 2025
Later from Bide Pharmatech
- Announcement on Planning to Conduct Foreign Exchange Hedging Business
- Report for Q3 2025
- Indicative Announcement on Shareholder's Equity Change Reaching 1%
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on the By-election of Non-independent Directors
Follow Bide Pharmatech into a list and get an email when it puts out news.
Follow Bide Pharmatech